Correlation Between Microbot Medical and BioLife Sciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Microbot Medical and BioLife Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microbot Medical and BioLife Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Microbot Medical and BioLife Sciences, you can compare the effects of market volatilities on Microbot Medical and BioLife Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microbot Medical with a short position of BioLife Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microbot Medical and BioLife Sciences.

Diversification Opportunities for Microbot Medical and BioLife Sciences

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Microbot and BioLife is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Microbot Medical and BioLife Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioLife Sciences and Microbot Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microbot Medical are associated (or correlated) with BioLife Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioLife Sciences has no effect on the direction of Microbot Medical i.e., Microbot Medical and BioLife Sciences go up and down completely randomly.

Pair Corralation between Microbot Medical and BioLife Sciences

Given the investment horizon of 90 days Microbot Medical is expected to generate 42.52 times less return on investment than BioLife Sciences. But when comparing it to its historical volatility, Microbot Medical is 9.33 times less risky than BioLife Sciences. It trades about 0.03 of its potential returns per unit of risk. BioLife Sciences is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  0.20  in BioLife Sciences on November 2, 2024 and sell it today you would lose (0.19) from holding BioLife Sciences or give up 95.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy99.8%
ValuesDaily Returns

Microbot Medical  vs.  BioLife Sciences

 Performance 
       Timeline  
Microbot Medical 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Microbot Medical are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Microbot Medical unveiled solid returns over the last few months and may actually be approaching a breakup point.
BioLife Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioLife Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, BioLife Sciences is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Microbot Medical and BioLife Sciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Microbot Medical and BioLife Sciences

The main advantage of trading using opposite Microbot Medical and BioLife Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microbot Medical position performs unexpectedly, BioLife Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioLife Sciences will offset losses from the drop in BioLife Sciences' long position.
The idea behind Microbot Medical and BioLife Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments